U.S. Navy to Deploy Floating Hospitals with Beckman Coulter Equipment on Board

Our hematology and microbiology systems will be on board U.S. naval ships providing general hospital relief during the COVID-19 outbreak.
U.S. Navy to Deploy Floating Hospitals with Beckman Coulter Equipment on Board

On March 18, President Trump announced that the U.S. Navy will deploy the USNS Comfort and Mercy Naval Floating Hospitals to New York and Los Angeles, respectively. These naval ships will provide general hospital relief, allowing local hospitals to focus their attention on COVID-19 cases. We’re proud to have hematology and microbiology systems on board to alleviate medical needs in those locations.

For more than 16 years, we have supplied the U.S. Navy with the medical equipment needed to support humanitarian relief operations both domestically and globally.

You can read more on the U.S. Department of Defense website.

Editorial Team
Editorial Team
The Beckman Coulter editorial team brings you timely news and resources focused on elevating clinical laboratory performance and advancing patient care.

Related Articles

Ready. Set. CLIA 2024!

Ready. Set. CLIA 2024!

The 2024 CLIA proposed acceptance limits for proficiency testing will be implemented January 2025.* Are you ready?
How High Sensitivity Testing Has Revolutionized Cardiac Care

How High Sensitivity Testing Has Revolutionized Cardiac Care

Each year, millions of patients visit the Emergency Department with chest pain. Incorporating high-sensitivity troponin testing is essential for detecting cardiac damage.
Using Anti-Müllerian Hormone to Determine Ovarian Reserve

Using Anti-Müllerian Hormone to Determine Ovarian Reserve

Globally, infertility impacts millions of couples. For women, one challenge can be a lack of ovulation. Learn how AMH testing is used to determine egg reserve and help couples achieve their dream of parenthood.